• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊切除术后综合征女性患者的消化不良与肠道微生物群

Dyspepsia and Gut Microbiota in Female Patients with Postcholecystectomy Syndrome.

作者信息

Georgescu Doina, Caraba Alexandru, Ionita Ioana, Lascu Ana, Hut Emil Florin, Dragan Simona, Ancusa Oana Elena, Suceava Ioana, Lighezan Daniel

机构信息

Department of Internal Medicine I, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Department of Functional Sciences, Discipline of Pathophysiology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

出版信息

Int J Womens Health. 2022 Jan 26;14:41-56. doi: 10.2147/IJWH.S342882. eCollection 2022.

DOI:10.2147/IJWH.S342882
PMID:35136356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8816732/
Abstract

BACKGROUND

Gallstone disease (GSD) represents one of the most frequent digestive disorders, highly reported in female gender. The purpose of the study was to explore the clinical and gut microbiota particularities of female patients with postcholecystectomy syndrome (PCS) and the possible relationship between gut dysbiosis (DB) and abdominal complaints.

PATIENTS AND METHODS

In total, 129 female participants: 104 outpatients divided into two equal groups, 52 PCS (+), 52 PCS (-) and 25 healthy controls were consecutively enrolled in this observational study. Patients underwent clinical examination with assessment of pain, bloating, transit disturbances, abdominal ultrasound/computer tomography/magnetic resonance imaging/endoscopic retrograde cholangiopancreatography, upper and lower digestive endoscopies. Laboratory work-ups and stool microbiology assessments were performed for all study participants (patients and controls). Stool microorganisms were identified by matrix-assisted laser desorption ionization - time-of-flight- mass spectrometry and in patients with DB also by next-generation sequencing.

RESULTS

Older age, complicated gallstones disease, associated conditions like diabetes mellitus/impaired glucose tolerance and irritable bowel syndrome were significantly present in PCS (+) group, as well as sedentary lifestyle and diets characterized by a low fiber intake (p<0.0001). PCS (+) patients displayed significant differences related to the incidence and severity of overall gut microbiota DB, decreased H index of biodiversity and the unbalanced Firmicutes/Bacteroidetes (F/B) ratios by comparison to the PCS (-) group (p<0.0001). Strong positive correlations of the severity of overall DB with bloating and the intestinal habit disorders, as well as of F/B ratios to all abdominal symptoms were noted.

CONCLUSION

PCS in female patients was associated with older age, sedentary lifestyle, specific dietary habits, history of complicated gallstone disease, diabetes mellitus/impaired glucose tolerance and irritable bowel syndrome, as well as gut microbiota particularities. Overall DB and unbalanced F/B ratios were strongly correlated to abdominal complaints.

摘要

背景

胆结石病(GSD)是最常见的消化系统疾病之一,在女性中发病率很高。本研究的目的是探讨胆囊切除术后综合征(PCS)女性患者的临床和肠道微生物群特征,以及肠道生态失调(DB)与腹部不适之间的可能关系。

患者与方法

本观察性研究共纳入129名女性参与者:104名门诊患者分为两组,每组52名,分别为PCS(+)组和PCS(-)组,另有25名健康对照者。患者接受了临床检查,评估疼痛、腹胀、排便紊乱情况,进行腹部超声/计算机断层扫描/磁共振成像/内镜逆行胰胆管造影、上消化道和下消化道内镜检查。对所有研究参与者(患者和对照者)进行了实验室检查和粪便微生物学评估。通过基质辅助激光解吸电离飞行时间质谱法鉴定粪便微生物,对于存在DB的患者,还通过下一代测序进行鉴定。

结果

PCS(+)组中年龄较大、患有复杂胆结石病、伴有糖尿病/糖耐量受损和肠易激综合征等相关疾病的情况明显较多,同时久坐不动的生活方式和低纤维摄入的饮食特点也较为显著(p<0.0001)。与PCS(-)组相比,PCS(+)患者在总体肠道微生物群DB发生率和严重程度、生物多样性H指数降低以及厚壁菌门/拟杆菌门(F/B)比例失衡方面存在显著差异(p<0.0001)。观察到总体DB严重程度与腹胀和肠道习惯紊乱之间存在强正相关,以及F/B比例与所有腹部症状之间存在强正相关。

结论

女性患者的PCS与年龄较大、久坐不动的生活方式、特定饮食习惯、复杂胆结石病病史、糖尿病/糖耐量受损和肠易激综合征以及肠道微生物群特征有关。总体DB和失衡的F/B比例与腹部不适密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/420776e9bf75/IJWH-14-41-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/6f7283b6fe99/IJWH-14-41-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/eb03056acd22/IJWH-14-41-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/b3c7a0276eb4/IJWH-14-41-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/f6805b4baaa6/IJWH-14-41-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/d3977fbea57d/IJWH-14-41-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/4b0eb3528d27/IJWH-14-41-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/7ce768d1c4f0/IJWH-14-41-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/f623d1af87af/IJWH-14-41-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/b02c3c0b6859/IJWH-14-41-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/1595a6e3a60c/IJWH-14-41-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/a321a7486fa5/IJWH-14-41-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/420776e9bf75/IJWH-14-41-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/6f7283b6fe99/IJWH-14-41-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/eb03056acd22/IJWH-14-41-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/b3c7a0276eb4/IJWH-14-41-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/f6805b4baaa6/IJWH-14-41-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/d3977fbea57d/IJWH-14-41-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/4b0eb3528d27/IJWH-14-41-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/7ce768d1c4f0/IJWH-14-41-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/f623d1af87af/IJWH-14-41-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/b02c3c0b6859/IJWH-14-41-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/1595a6e3a60c/IJWH-14-41-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/a321a7486fa5/IJWH-14-41-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a5/8816732/420776e9bf75/IJWH-14-41-g0012.jpg

相似文献

1
Dyspepsia and Gut Microbiota in Female Patients with Postcholecystectomy Syndrome.胆囊切除术后综合征女性患者的消化不良与肠道微生物群
Int J Womens Health. 2022 Jan 26;14:41-56. doi: 10.2147/IJWH.S342882. eCollection 2022.
2
Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients.中老年患者的胆结石疾病与肠道微生物群的细菌代谢表现
Int J Gen Med. 2022 Jun 8;15:5513-5531. doi: 10.2147/IJGM.S350104. eCollection 2022.
3
Cholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?胆固醇胆结石与他汀类药物的长期使用:肠道微生物群失调能否弥合不确定性?
Diagnostics (Basel). 2024 Jun 12;14(12):1234. doi: 10.3390/diagnostics14121234.
4
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
5
Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.识别肠微生物组和代谢产物特征在肠易激综合征患者中。
Front Cell Infect Microbiol. 2019 Oct 18;9:346. doi: 10.3389/fcimb.2019.00346. eCollection 2019.
6
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis.肝硬化患者的小肠转运与肠道微生物群改变
Front Physiol. 2018 May 1;9:470. doi: 10.3389/fphys.2018.00470. eCollection 2018.
7
Characterization of functional biliary pain and dyspeptic symptoms in patients with sphincter of Oddi dysfunction: effect of papillotomy.Oddi括约肌功能障碍患者功能性胆绞痛和消化不良症状的特征:乳头切开术的效果
World J Gastroenterol. 2006 Nov 14;12(42):6850-6. doi: 10.3748/wjg.v12.i42.6850.
8
Proteobacteria Acts as a Pathogenic Risk-Factor for Chronic Abdominal Pain and Diarrhea in Post-Cholecystectomy Syndrome Patients: A Gut Microbiome Metabolomics Study.变形菌门在胆囊切除术后综合征患者慢性腹痛和腹泻中的致病风险作用:一项肠道微生物组代谢组学研究。
Med Sci Monit. 2019 Sep 29;25:7312-7320. doi: 10.12659/MSM.915984.
9
[Gastric complaints or postcholecystectomy syndrome?].[胃部不适还是胆囊切除术后综合征?]
Pol Merkur Lekarski. 2008 Sep;25(147):221-5.
10
Taxonomic composition and biodiversity of the gut microbiome from patients with irritable bowel syndrome, ulcerative colitis, and asthma.肠易激综合征、溃疡性结肠炎和哮喘患者肠道微生物群的分类组成和生物多样性。
Vavilovskii Zhurnal Genet Selektsii. 2021 Dec;25(8):864-873. doi: 10.18699/VJ21.100.

引用本文的文献

1
Advances in research on the role of gut microbiota in the pathogenesis and precision management of gallstone disease.肠道微生物群在胆结石病发病机制及精准管理中的作用研究进展
Front Med (Lausanne). 2025 Jun 25;12:1535355. doi: 10.3389/fmed.2025.1535355. eCollection 2025.
2
Clinical perspectives on post-cholecystectomy syndrome: a narrative review.胆囊切除术后综合征的临床观点:一项叙述性综述。
Ann Med. 2025 Dec;57(1):2496408. doi: 10.1080/07853890.2025.2496408. Epub 2025 Apr 30.
3
MiR-33 as a novel diagnostic biomarker for distinguishing cholesterol from adenomatous polyps: a case-control study.

本文引用的文献

1
Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.抗生素相关的菌群失调会影响肠道微生物群在实验性结肠炎模型中进行粪便微生物群移植时控制肠道炎症的能力。
Microbiome. 2021 Feb 6;9(1):39. doi: 10.1186/s40168-020-00991-x.
2
Antibiotics as Major Disruptors of Gut Microbiota.抗生素作为肠道微生物群的主要干扰因素。
Front Cell Infect Microbiol. 2020 Nov 24;10:572912. doi: 10.3389/fcimb.2020.572912. eCollection 2020.
3
Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence.
MiR-33作为区分胆固醇性息肉与腺瘤性息肉的新型诊断生物标志物:一项病例对照研究。
Hereditas. 2025 Mar 14;162(1):37. doi: 10.1186/s41065-025-00407-6.
4
Cholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?胆固醇胆结石与他汀类药物的长期使用:肠道微生物群失调能否弥合不确定性?
Diagnostics (Basel). 2024 Jun 12;14(12):1234. doi: 10.3390/diagnostics14121234.
5
Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion's Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker.使用Allurion可吞咽胃内球囊评估肥胖治疗中的减肥效果:一项利用Scale App健康追踪器的回顾性研究。
Clin Pract. 2024 May 6;14(3):765-778. doi: 10.3390/clinpract14030061.
6
NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden.非酒精性脂肪性肝炎/非酒精性脂肪性肝病相关肝细胞癌:一项额外负担。
Life (Basel). 2023 Dec 23;14(1):25. doi: 10.3390/life14010025.
7
Comparative Analysis of Antibiotic Resistance in Acute Cholangitis Patients with Stent Placement and Sphincterotomy Interventions.急性胆管炎患者支架置入与括约肌切开术干预后抗生素耐药性的比较分析
Life (Basel). 2023 Nov 13;13(11):2205. doi: 10.3390/life13112205.
8
Colorectal Carcinomas: Searching for New Histological Parameters Associated with Lymph Node Metastases.结直肠癌:寻找与淋巴结转移相关的新组织学参数。
Medicina (Kaunas). 2023 Oct 2;59(10):1761. doi: 10.3390/medicina59101761.
9
Cholecystectomy Significantly Alters Gut Microbiota Homeostasis and Metabolic Profiles: A Cross-Sectional Study.胆囊切除术显著改变肠道微生物组稳态和代谢谱:一项横断面研究。
Nutrients. 2023 Oct 17;15(20):4399. doi: 10.3390/nu15204399.
10
Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?肝硬化患者的门静脉血栓形成:出了什么问题?
Int J Gen Med. 2023 Aug 28;16:3889-3906. doi: 10.2147/IJGM.S413438. eCollection 2023.
肠道微生物群与结直肠癌的发生发展:深入探究腺瘤-癌序列
Biomedicines. 2020 Nov 10;8(11):489. doi: 10.3390/biomedicines8110489.
4
Bacterial Alterations in Post-Cholecystectomy Patients Are Associated With Colorectal Cancer.胆囊切除术后患者的细菌改变与结直肠癌有关。
Front Oncol. 2020 Aug 12;10:1418. doi: 10.3389/fonc.2020.01418. eCollection 2020.
5
Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation.肠道菌群失衡会影响胆汁酸代谢,与胆结石形成有关。
BMC Gastroenterol. 2020 Mar 6;20(1):59. doi: 10.1186/s12876-020-01195-1.
6
Migraine without Aura and Subclinical Atherosclerosis in Young Females: Is Gut Microbiota to Blame?年轻女性中无先兆偏头痛与亚临床动脉粥样硬化:是肠道微生物群的错吗?
Medicina (Kaunas). 2019 Dec 16;55(12):786. doi: 10.3390/medicina55120786.
7
Proteobacteria Acts as a Pathogenic Risk-Factor for Chronic Abdominal Pain and Diarrhea in Post-Cholecystectomy Syndrome Patients: A Gut Microbiome Metabolomics Study.变形菌门在胆囊切除术后综合征患者慢性腹痛和腹泻中的致病风险作用:一项肠道微生物组代谢组学研究。
Med Sci Monit. 2019 Sep 29;25:7312-7320. doi: 10.12659/MSM.915984.
8
What if body fat percentage association with FINDRISC score leads to a better prediction of type 2 diabetes mellitus?如果体脂百分比与芬兰糖尿病风险评分(FINDRISC)之间的关联能够更好地预测2型糖尿病会怎样?
Rom J Morphol Embryol. 2019;60(1):205-210.
9
Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.肠易激综合征患者的肠道微生物群:系统评价。
Gastroenterology. 2019 Jul;157(1):97-108. doi: 10.1053/j.gastro.2019.03.049. Epub 2019 Mar 30.
10
The role of intestinal microbiota in cardiovascular disease.肠道微生物群在心血管疾病中的作用。
J Cell Mol Med. 2019 Apr;23(4):2343-2350. doi: 10.1111/jcmm.14195. Epub 2019 Feb 3.